{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:00:30Z","timestamp":1785225630742,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2407-11-469","type":"journal-article","created":{"date-parts":[[2011,11,18]],"date-time":"2011-11-18T07:29:22Z","timestamp":1321601362000},"source":"Crossref","is-referenced-by-count":76,"title":["Results of combined treatment of anaplastic thyroid carcinoma (ATC)"],"prefix":"10.1186","volume":"11","author":[{"given":"Olfa","family":"Derbel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Limem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"S\u00e9gura-Ferlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Lifante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Carrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Peix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Borson-Chazot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Bournaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Droz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"de la Fouchardi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,1]]},"reference":[{"key":"2955_CR1","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1530\/EJE-06-0677","volume":"156","author":"E Brignardello","year":"2007","unstructured":"Brignardello E, Gallo M, Baldi I, Palestini N, Piovesan A, Grossi E, Ciccone G, Boccuzzi G: Anaplastic thyroid carcinoma: clinical outcome of 30 consecutive patients referred to a single institution in the past 5 years. Eur J Endocrinol. 2007, 156: 425-430. 10.1530\/EJE-06-0677.","journal-title":"Eur J Endocrinol"},{"key":"2955_CR2","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s002680020166","volume":"25","author":"I Sugitani","year":"2001","unstructured":"Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A: Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid. World J Surg. 2001, 25: 617-622.3. 10.1007\/s002680020166.","journal-title":"World J Surg"},{"key":"2955_CR3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/00001622-200301000-00012","volume":"15","author":"JL Pasieka","year":"2003","unstructured":"Pasieka JL: Anaplastic thyroid cancer. Curr Opin Oncol. 2003, 15: 78-83. 10.1097\/00001622-200301000-00012.","journal-title":"Curr Opin Oncol"},{"key":"2955_CR4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1245\/ASO.2006.05.042","volume":"13","author":"C Are","year":"2006","unstructured":"Are C, Shaha AR: Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors and treatment approaches. Ann Surg Oncol. 2006, 13: 453-464.5. 10.1245\/ASO.2006.05.042.","journal-title":"Ann Surg Oncol"},{"key":"2955_CR5","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1038\/sj.bjc.6600361","volume":"86","author":"J Tennvall","year":"2002","unstructured":"Tennvall J, Lundell G, Wahlberg P, Bergenfelz A, Grimelius L, Akerman M, Hjelm Skog AL, Wallin G: Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery. Br J Cancer. 2002, 86: 1848-1853.6. 10.1038\/sj.bjc.6600361.","journal-title":"Br J Cancer"},{"key":"2955_CR6","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.ijrobp.2004.05.032","volume":"60","author":"R De Crevoisier","year":"2004","unstructured":"De Crevoisier R, Baudin E, Bachelot A, Leboulleux S, Travagli JP, Caillou B, Schlumberger M: Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy and hyperfractionated accelerated external radiotherapy. Int J Radiat Oncol Biol Phys. 2004, 60: 1137-1143. 10.1016\/j.ijrobp.2004.05.032.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2955_CR7","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s00595-003-2737-6","volume":"34","author":"M Kihara","year":"2004","unstructured":"Kihara M, Miyauchi A, Yamauchi A, Yokomise H: Prognostic factors of anaplastic thyroid carcinoma. Surg Today. 2004, 34: 394-398. 10.1007\/s00595-003-2737-6.","journal-title":"Surg Today"},{"key":"2955_CR8","first-page":"87","volume-title":"AJCC Cancer Staging Manual","author":"SB Edge","year":"2010","unstructured":"Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A: AJCC Cancer Staging Manual. 2010, New York, NY: Springer, 87-96. 7","edition":"7"},{"key":"2955_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/ajcp\/83.2.135","volume":"83","author":"ML Carcangiu","year":"1985","unstructured":"Carcangiu ML, Steeper T, Zampi G, Rosai J: Anaplastic thyroid carcinoma. A study of 70 cases. Am J Clin Pathol. 1985, 83: 135-158.","journal-title":"Am J Clin Pathol"},{"key":"2955_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/B978-0-7216-0139-7.50022-3","volume-title":"Textbook of endocrine surgery","author":"IB Rosen","year":"2005","unstructured":"Rosen IB, Asa SL, Brierley JD: Anaplastic carcinoma of the thyroid gland. Textbook of endocrine surgery. Edited by: Clark OH, Duh QY, Kebebew E. 2005, Philadelphia, PA: Elsevier Saunders, 159-167."},{"key":"2955_CR11","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1067\/msy.2001.118266","volume":"130","author":"B McIver","year":"2001","unstructured":"McIver B, Hay ID, Giuffrida DF, Dvorak CE, Grant CS, Thompson GB, van Heerden JA, Goellner JR: Anaplastic thyroid carcinoma: a 50-years experience at a single institution. Surgery. 2001, 130: 1028-1034. 10.1067\/msy.2001.118266.","journal-title":"Surgery"},{"key":"2955_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1445-2197.2004.03062.x","volume":"74","author":"MJ Veness","year":"2004","unstructured":"Veness MJ, Porter GS, Morgan GJ: Anaplastic thyroid carcinoma: dismal outcome despite current treatment approach. ANZ J Surg. 2004, 74: 559-562. 10.1111\/j.1445-2197.2004.03062.x.","journal-title":"ANZ J Surg"},{"key":"2955_CR13","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1002\/1097-0142(20010615)91:12<2335::AID-CNCR1266>3.0.CO;2-1","volume":"91","author":"PI Haigh","year":"2001","unstructured":"Haigh PI, Ituarte PH, Wu HS, Treseler PA, Posner MD, Quivey JM, Duh QY, Clark OH: Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer. 2001, 91: 2335-2342. 10.1002\/1097-0142(20010615)91:12<2335::AID-CNCR1266>3.0.CO;2-1.","journal-title":"Cancer"},{"key":"2955_CR14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.radonc.2009.02.016","volume":"92","author":"AT Swaak-Kragten","year":"2009","unstructured":"Swaak-Kragten AT, de Wilt JH, Schmitz PI, Bontenbal M, Levendag PC: Multimodality treatment for anaplastic thyroid carcinoma--treatment outcome in 75 patients. Radiother Oncol. 2009, 92: 100-104. 10.1016\/j.radonc.2009.02.016.","journal-title":"Radiother Oncol"},{"key":"2955_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0360-3016(93)90182-U","volume":"26","author":"PC Levendag","year":"1993","unstructured":"Levendag PC, De Porre PM, van Putten WL: Anaplastic carcinoma of the thyroid gland treated by radiation therapy. Int J Radiat Oncol Biol Phys. 1993, 26: 125-128. 10.1016\/0360-3016(93)90182-U.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2955_CR16","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1002\/1097-0142(19851101)56:9<2155::AID-CNCR2820560903>3.0.CO;2-E","volume":"56","author":"K Shimaoka","year":"1985","unstructured":"Shimaoka K, Schoenfeld D, DeWys W, Creech RH, DeConti R: A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma. Cancer. 1985, 56: 2155-2160. 10.1002\/1097-0142(19851101)56:9<2155::AID-CNCR2820560903>3.0.CO;2-E.","journal-title":"Cancer"},{"key":"2955_CR17","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1089\/thy.2000.10.587","volume":"10","author":"KB Ain","year":"2000","unstructured":"Ain KB, Egorin MJ, DeSimone PA: Treatment of anaplastic thyroid carcinoma with paclitaxel: Phase 2 trial using ninety-six hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group. Thyroid. 2000, 10: 587-594. 10.1089\/thy.2000.10.587.","journal-title":"Thyroid"},{"key":"2955_CR18","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/jso.20691","volume":"94","author":"LD Green","year":"2006","unstructured":"Green LD, Mack L, Pasieka JL: Anaplastic thyroid cancer and primary thyroid lymphoma: a review of these rare thyroid malignancies. J Surg Oncol. 2006, 94: 725-736. 10.1002\/jso.20691.","journal-title":"J Surg Oncol"},{"key":"2955_CR19","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/hed.10277","volume":"25","author":"SM Wiseman","year":"2003","unstructured":"Wiseman SM, Loree TR, Rigual NR, Hicks WL, Douglas WG, Anderson GR, Stoler DL: Anaplastic transformation of thyroid cancer: review of clinical, pathologic, and molecular evidence provides new insights into disease biology and future therapy. Head Neck. 2003, 25: 662-670. 10.1002\/hed.10277.","journal-title":"Head Neck"},{"key":"2955_CR20","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1200\/JCO.2008.16.3279","volume":"26","author":"V Gupta-Abramson","year":"2008","unstructured":"Gupta-Abramson V, Troxel AB, Nellore A, Puttaswamy K, Redlinger M, Ransone K, Mandel SJ, Flaherty KT, Loevner LA, O'Dwyer PJ, Brose MS: Phase II trial of sorafenib in advanced thyroid cancer. J Clin Oncol. 2008, 26: 4714-4719. 10.1200\/JCO.2008.16.3279.","journal-title":"J Clin Oncol"},{"key":"2955_CR21","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1200\/JCO.2008.18.2717","volume":"27","author":"RT Kloos","year":"2009","unstructured":"Kloos RT, Ringel MD, Knopp MV, Hall NC, King M, Stevens R, Liang J, Wakely PE, Vasko VV, Saji M, Rittenberry J, Wei L, Arbogast D, Collamore M, Wright JJ, Grever M, Shah MH: Phase II trial of sorafenib in metastatic thyroid cancer. J Clin Oncol. 2009, 27: 1675-1684. 10.1200\/JCO.2008.18.2717.","journal-title":"J Clin Oncol"},{"key":"2955_CR22","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1210\/jc.2007-0027","volume":"92","author":"SC Yeung","year":"2007","unstructured":"Yeung SC, She M, Yang H, Pan J, Sun L, Chaplin D: Combination chemotherapy including combretastatin A4 phosphate and paclitaxel is effective against anaplastic thyroid cancer in a nude mouse xenograft model. J Clin Endocrinol Metab. 2007, 92: 2902-2909. 10.1210\/jc.2007-0027.","journal-title":"J Clin Endocrinol Metab"},{"key":"2955_CR23","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1158\/1541-7786.MCR-09-0117","volume":"7","author":"TH Kim","year":"2009","unstructured":"Kim TH, Lee SY, Rho JH, Jeong NY, Soung YH, Jo WS, Kang DY, Kim SH, Yoo YH: Mutant p53 (G199V) gains antiapoptotic function through signal transducer and activator of transcription 3 in anaplastic thyroid cancer cells. Mol Cancer Res. 2009, 7: 1645-1654. 10.1158\/1541-7786.MCR-09-0117.","journal-title":"Mol Cancer Res"},{"key":"2955_CR24","volume-title":"35th ESMO congress","author":"R Elisei","year":"2010","unstructured":"Elisei R, Sosa JA, Gramza A, Marur B, Haugen S, Remick C, Bal B, Jarzab L, Licitra J, Balkissoon : Randomized phase 2\/3 trial of a tumor vascular disrupting agent, fostretabulin tromethamine (CA4P), with carboplatin and paclitaxel in anaplastic thyroid cancer (ATC): interim safety and efficacy results of the fact trial. 35th ESMO congress. 2010, Milan, Italy, abstr 1006"},{"key":"2955_CR25","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1089\/thy.2010.0057","volume":"20","author":"HT Ha","year":"2010","unstructured":"Ha HT, Lee JS, Urba S, Koenig RJ, Sisson J, Giordano T, Worden FP: A phase II study of imatinib in patients with advanced anaplastic thyroid cancer. Thyroid. 2010, 20: 975-980. 10.1089\/thy.2010.0057.","journal-title":"Thyroid"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-469.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-11-469\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-469","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T20:18:36Z","timestamp":1468354716000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-11-469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["2955"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-11-469","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,1]]},"article-number":"469"}}